SCHEMBL7426280

SCHEMBL7426280

CCCC(=O)C(C(=O)O)N(C)Cc1cccs1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ RIPK1 Q13546 1/20 0.46
▸ CYP2C19 P33261 1/20 0.45
▸ TRPM8 Q7Z2W7 4/20 0.43
▸ HSD11B1 P28845 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418946 0.76 HSD11B1 (0.40) TRPM8HSD11B1KMT2A
SCHEMBL7426272 0.74 TRPM8 (0.48) POLBTDP1RIPK1TRPM8ALDH1A1
SCHEMBL29868698 0.72 POLB (0.73) POLBTDP1RIPK1TRPM8LMNA
SCHEMBL21426224 0.69 HPGD (0.53) POLBTDP1RIPK1TRPM8HSD11B1
SCHEMBL6302633 0.68 CYP2C19 (0.49) POLBTDP1CYP2C19TRPM8ALDH1A1
SCHEMBL28391134 0.68 POLB (0.54) POLBTDP1RIPK1CYP2C19TRPM8
SCHEMBL6122487 0.68 RIPK1 (0.60) POLBTDP1RIPK1TRPM8HSD11B1
SCHEMBL28672259 0.68 CYP2C19 (0.53) POLBTDP1RIPK1CYP2C19TRPM8
SCHEMBL8326400 0.68 CYP2C19 (0.67) POLBTDP1CYP2C19ALDH1A1LMNA
SCHEMBL2400082 0.67 CYP2C19 (0.66) POLBTDP1CYP2C19TRPM8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265903-A1 THIEPINO[3,2-B]DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-12-18 — — EP disclosed
US-6420383-B1 CALCIUM CHANNEL BLOCKERS, HYPERSENSITIVITY, ALLERGY, ASTHMA, BRONCHOSPASM, DYSMENORRHEA, ESOPHAGEAL SPASM, GLAUCOMA, PREMATURE LABOR, URINARY TRACT DISORDERS, GASTROINTESTINAL MOTILITY DISORDERS AND CARDIOVASCULAR DISORDERS. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-07-16 — — US disclosed
WO-2001070748-A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-09-27 — — WO disclosed
Send feedback